| 72.35 Delayed Data As of Oct 19 |  +0.14 / +0.19%Today’s Change | 52.83 Today|||52-Week Range 72.89 | +28.58% Year-to-Date |
| Previous close | 72.21 |
| Today’s open | 72.30 |
| Day’s range | 71.94 - 72.66 |
| Volume | 14,513,382 |
| Average volume (3 months) | 8,715,059 |
| Market cap | $192.0B |
| Earnings growth (last year) | -38.30% |
| Earnings growth (this year) | +7.72% |
| Earnings growth (next 5 years) | +7.50% |
| Revenue growth (last year) | +1.23% |
| P/E ratio | 144.7 |
| Price/Sales | 3.87 |
| Price/Book | 5.67 |
| Today’s change | Today’s % change | |
|---|---|---|
| NVSNovartis | +0.95 | +1.10% |
| ABBVAbbVie | -1.93 | -2.15% |
| PFEPfizer | +0.50 | +1.14% |
| LLYEli Lilly and Co | -1.39 | -1.23% |
| Next reporting date | October 25, 2018 |
| EPS forecast (this quarter) | $1.13 |
| Annual revenue (last year) | $40.0B |
| Annual profit (last year) | $2.4B |
| Net profit margin | 5.99% |
Sector Health Technology |
Industry Pharmaceuticals: Major |
Chairman, President & Chief Executive Officer Kenneth C. Frazier |
CFO & Executive Vice President-Global Services Robert M. Davis |
Corporate headquarters Kenilworth, New Jersey |
